Immediate Impact
55 standout
Citing Papers
Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Future therapies for cystic fibrosis
2023 Standout
Works of Tamara Everington being referenced
101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Transient Expression of Human Factor IX (hFIX)
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Tamara Everington | 99 | 60 | 83 | 230 | 186 | 22 | 476 | |
| M. Bhavnani | 98 | 35 | 68 | 175 | 330 | 23 | 506 | |
| S. C. Tso | 55 | 60 | 39 | 161 | 190 | 24 | 467 | |
| Asher Winder | 36 | 64 | 59 | 119 | 222 | 21 | 536 | |
| Hélène Haguet | 79 | 15 | 99 | 153 | 240 | 22 | 447 | |
| T. Eng Gan | 87 | 53 | 102 | 148 | 132 | 28 | 472 | |
| Günay Balta | 44 | 67 | 38 | 78 | 277 | 32 | 511 | |
| T Barbui | 103 | 63 | 64 | 70 | 241 | 31 | 443 | |
| Takahiro Nakasaki | 162 | 61 | 89 | 72 | 304 | 27 | 566 | |
| C. M. Schambeck | 154 | 81 | 72 | 56 | 239 | 27 | 452 | |
| Andrea Cortese Hassett | 54 | 114 | 48 | 114 | 278 | 13 | 544 |
All Works
Login with ORCID to disown or claim papers
Loading papers...